South San Francisco, CA · Founded 2022 · Privately Held (backing)
Developer of an oncology technology platform designed for cancer treatment. Shenandoah Therapeutics is based in South San Francisco, CA and was founded in 2022. Its last reported valuation was $37 million in Mar 2025. It has raised $21.5 million across 1 recorded round; the latest was a $21.5 million early-stage round in May 2025.
Last reported valuation
$37.0M
Oct 2026
Priced at
—
Total raised
$21.5M
Last round
Early Stage VC
May 2025
Team — not yet on record
No current team members for Shenandoah Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Private Market View
More of Shenandoah Therapeutics with a free Private Market View account
·Watch Shenandoah Therapeutics: the Monday email on marks, rounds and moves
